Loading stock data…
$6.16-0.18 (-2.84%)
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.
Inogen, Inc. in the Healthcare sector is trading at $6.16 with a market capitalization of $139M. Wall Street consensus targets $12.00 (2 analysts), implying a +94.8% move over the next 12 months. The stock is currently 33% below its 52-week high of $9.13, remaining 1.0% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 71 is overbought against a weak tape. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $95.08M↑ | $85.11M↑ | $81.72M↓ | $92.39M↑ | $92.28M |
| Gross Profit | $43.27M↑ | $37.86M↑ | $35.24M↓ | $41.32M | $41.34M |
| Operating Income | -$5.10M↑ | -$9.34M↓ | -$9.31M↓ | -$7.12M↓ | -$6.13M |
| Net Income | -$3.85M↑ | -$8.32M↓ | -$7.13M↓ | -$5.29M↓ | -$4.15M |
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen thera...